Ontology highlight
ABSTRACT: Background
Motor functional neurological disorder (mFND) is a clinical diagnosis with reliable features; however, patients are reluctant to accept the diagnosis and physicians themselves bear doubts on potential misdiagnoses. The identification of a positive biomarker could help limiting unnecessary costs of multiple referrals and investigations, thus promoting early diagnosis and allowing early engagement in appropriate therapy.Objectives
To test whether resting-state (RS) functional magnetic resonance imaging could discriminate patients suffering from mFND from healthy controls.Methods
We classified 23 mFND patients and 25 age- and gender-matched healthy controls based on whole-brain RS functional connectivity (FC) data, using a support vector machine classifier and the standard Automated Anatomic Labeling (AAL) atlas, as well as two additional atlases for validation.Results
Accuracy, specificity and sensitivity were over 68% (p = 0.004) to discriminate between mFND patients and controls, with consistent findings between the three tested atlases. The most discriminative connections comprised the right caudate, amygdala, prefrontal and sensorimotor regions. Post-hoc seed connectivity analyses showed that these regions were hyperconnected in patients compared to controls.Conclusions
The good accuracy to discriminate patients from controls suggests that RS FC could be used as a biomarker with high diagnostic value in future clinical practice to identify mFND patients at the individual level.
SUBMITTER: Wegrzyk J
PROVIDER: S-EPMC5651543 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Wegrzyk Jennifer J Kebets Valeria V Richiardi Jonas J Galli Silvio S de Ville Dimitri Van DV Aybek Selma S
NeuroImage. Clinical 20171012
<h4>Background</h4>Motor functional neurological disorder (mFND) is a clinical diagnosis with reliable features; however, patients are reluctant to accept the diagnosis and physicians themselves bear doubts on potential misdiagnoses. The identification of a positive biomarker could help limiting unnecessary costs of multiple referrals and investigations, thus promoting early diagnosis and allowing early engagement in appropriate therapy.<h4>Objectives</h4>To test whether resting-state (RS) funct ...[more]